Valuation: Baxter International Inc.

Capitalization 9.1B 7.78B 7.17B 6.77B 12.57B 852B 12.89B 83.97B 33.01B 407B 34.16B 33.43B 1,454B P/E ratio 2026 *
28.1x
P/E ratio 2027 * 21.1x
Enterprise value 15.57B 13.31B 12.27B 11.58B 21.51B 1,458B 22.06B 144B 56.49B 696B 58.45B 57.21B 2,488B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.3x
Free-Float
74.36%
Yield 2026 *
0.22%
Yield 2027 * 0.24%
1 day+2.80%
1 week+5.89%
Current month+4.94%
1 month+1.32%
3 months-10.28%
6 months-20.26%
Current year-7.74%
1 week 16.81
Extreme 16.81
17.78
1 month 15.73
Extreme 15.73
17.84
Current year 15.73
Extreme 15.73
22.41
1 year 15.73
Extreme 15.73
32.68
3 years 15.73
Extreme 15.73
50.21
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Director of Finance/CFO 52 16/03/2026
Chief Tech/Sci/R&D Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 75 06/02/2017
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
+2.80%+5.89%-36.67%-59.17% 9.1B
+0.39%-1.57%-20.64%-2.82% 175B
+0.91%+1.99%+6.15%+7.86% 113B
-0.53%-0.57%+12.24%+90.66% 62.08B
+0.79%+4.98%+93.48%+104.45% 61.26B
+0.78%+0.07%-22.97%-39.36% 44.26B
+3.55%+7.61% - - 38.33B
-1.41%-0.14%-4.57%-45.72% 24.29B
+1.02%+2.22%+1.70%+15.24% 22.05B
+1.01%-3.12%-19.45%+11.97% 19.71B
Average +0.93%+1.35%+1.03%+9.23% 56.94B
Weighted average by Cap. +0.69%+0.78%+3.30%+18.08%

Financials

2026 *2027 *
Net sales 11.36B 9.7B 8.95B 8.44B 15.69B 1,064B 16.09B 105B 41.2B 508B 42.63B 41.73B 1,814B 11.61B 9.92B 9.14B 8.63B 16.04B 1,087B 16.44B 107B 42.11B 519B 43.57B 42.65B 1,854B
Net income 378M 322M 297M 281M 521M 35.35B 535M 3.48B 1.37B 16.88B 1.42B 1.39B 60.3B 438M 374M 345M 326M 605M 41.01B 620M 4.04B 1.59B 19.58B 1.64B 1.61B 69.95B
Net Debt 6.47B 5.53B 5.1B 4.81B 8.94B 606B 9.17B 59.72B 23.48B 289B 24.29B 23.78B 1,034B 5.99B 5.12B 4.72B 4.45B 8.28B 561B 8.49B 55.29B 21.74B 268B 22.49B 22.01B 957B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
13/04/26 17.63 $ +2.80% 12,110,226
10/04/26 17.15 $ -0.87% 3,536,516
09/04/26 17.30 $ +0.35% 5,440,026
08/04/26 17.24 $ +3.73% 6,358,471
07/04/26 16.62 $ -0.18% 4,742,257
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
17.63USD
Average target price
22.12USD
Spread / Average Target
+25.44%

Quarterly revenue - Rate of surprise